+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID02073500

Study of Peritoneal Surface Malignancies Identifying Biomarkers and Exploring Treatment with Cytoreductive Surgery and Heated Chemotherapy

Led by Oslo University Hospital · Updated on 2021-07-28

300

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying peritoneal surface malignancies PSM, a group of cancers affecting the lining of the abdomen, to improve treatment selection and outcomes. The study aims to find biomarkers that predict disease recurrence and prognosis and to explore new treatment strategies through animal models. This research is based on extensive experience, a large biobank, and novel models developed at a leading hospital. Participants are patients diagnosed with PSM who undergo cytoreductive surgery CRS combined with hyperthermic intraperitoneal chemotherapy HIPEC. CRS involves removing all visible tumors, while HIPEC delivers heated chemotherapy directly into the abdomen to target remaining cancer cells. This observational study collects and analyzes tissue and blood samples during treatment to better understand the disease and refine patient selection. During the study, participants will have their metastatic tissue and blood specimens collected for analysis. Researchers will monitor overall survival and disease-free survival over five years to assess outcomes. The study does not involve additional experimental treatments but focuses on gathering valuable data to guide future therapies. Participants progress will be tracked through routine clinical care and follow-up visits up to five years after treatment.

CONDITIONS

Brief Title

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

Research Team

K

Kjersti Flatmark, MD PhD

A

Annette Torgunrud Kristensen, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here